Centre allows states to buy COVID-19 vaccines directly from makers, opens direct import for private players; key changes from 1 May

The Centre's move comes amid a countrywide shortage of vaccine doses. Several states, including Maharashtra, Gujarat, Odisha, West Bengal, and Andhra Pradesh, have demanded additional doses from the Centre over the last few weeks

FP Staff April 19, 2021 20:08:23 IST
Centre allows states to buy COVID-19 vaccines directly from makers, opens direct import for private players; key changes from 1 May

Representational image. AFP

The Centre on Monday announced a slew of changes to India's vaccination policy, including opening the vaccination for everyone over the age of 18 and allowing state governments to procure the vaccines directly from the manufacturers from 1 May.

Follow LIVE updates on COVID-19 here

Following are the points from the Centre's order:

  1. Vaccine manufacturers will supply 50 percent of their monthly doses to the Centre and will be free to supply to remaining to state governments and to private buyers in the open market.
  2. Vaccine manufacturers will "transparently" quote their price for the doses supplied to the state government and private buyers before 1 May. "The eligibility through this channel will be opened up to all adults," the order said.
  3. Vaccination will continue at the Centre's vaccination centres,  and will be provided free for healthcare workers, frontline workers, and people above the age of 45.
  4. All vaccination operations will be part of the National Vaccination Programme and will need to follow all protocol like logging beneficiaries on the CoWin app and AEFI reporting. Stocks and price per vaccination applicable in all centres will also have to be reported in real-time.
  5. The division of vaccine supply between the Centre and other stakeholders will be applicable for all vaccines manufactured in the country. The Centre also made the direct import of vaccines available for state governments and private players.
  6. The Centre will allocate vaccines to states and UTs from its share depending on the extent of infection and efficiency of that particular government. Wastage of vaccine will also be considered in this criteria and will affect criteria negatively.
  7. The second dose of vaccine for healthcare and frontline workers will be given priority.

The Union Health Ministry said the important decision to allow vaccination to everyone above the age of 18 from May 1 was taken in a meeting chaired by Prime Minister Narendra Modi.

"Prime Minister said that the government has been working hard for over a year to ensure that maximum numbers of Indians are able to get the vaccine in the shortest possible of time. He added that India is vaccinating people at world record pace and we will continue this with even greater momentum," it added.

The Centre's move comes amid a countrywide shortage of vaccine doses. Several states, including Maharashtra, Gujarat, Odisha, West Bengal, and Andhra Pradesh, have demanded additional doses from the Centre over the last few weeks.

With inputs from agencies

Updated Date:

also read

COVID-19 vaccine: In a 'philanthropic gesture', SII reduces Covishield price to Rs 300 per dose for states
India

COVID-19 vaccine: In a 'philanthropic gesture', SII reduces Covishield price to Rs 300 per dose for states

This follows widespread criticism of the pricing policy of the SII, which sold the initial doses of Covishield to the Central Government at Rs 150 per dose

Brazil’s COVID-19 toll crosses 4,00,000; less than 6% citizens fully vaccinated, research finds
World

Brazil’s COVID-19 toll crosses 4,00,000; less than 6% citizens fully vaccinated, research finds

President Jair Bolsonaro, under investigation over his administration's handling of the crisis, has attacked mayors and governors who have enforced restrictions

COVID-19 vaccination: More than 16.71 crore doses administered so far, says Centre
India

COVID-19 vaccination: More than 16.71 crore doses administered so far, says Centre

The health ministry said nearly 3 lakh beneficiaries in the 18-44 age group received their first dose of COVID-19 vaccine on Friday